Wako Chemicals USA, Inc.: FDA filings under this applicant name
FDA lists 123 510(k) clearances under the applicant name “Wako Chemicals USA, Inc.” (first 1981, latest 2011), plus 1 De Novo decision, across 59 product codes in 4 review panels. Median 510(k) review time under this name: 52 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| JIT | Calibrator, Secondary | 15 | 15 |
| DFC | Lipoprotein, Low-Density, Antigen, Antiserum, Control | 9 | 9 |
| JIS | Calibrator, Primary | 7 | 7 |
| JIX | Calibrator, Multi-Analyte Mixture | 4 | 4 |
| JJX | Single (Specified) Analyte Controls (Assayed And Unassayed) | 4 | 4 |
| KNK | Acid, Uric, Uricase (Colorimetric) | 4 | 4 |
| CEK | Biuret (Colorimetric), Total Protein | 3 | 3 |
| CHH | Enzymatic Esterase--Oxidase, Cholesterol | 3 | 3 |
| CIT | Nadh Oxidation/Nad Reduction, Ast/Sgot | 3 | 3 |
| DCK | C-Reactive Protein, Antigen, Antiserum, And Control | 3 | 3 |
Plus 49 more product codes.
Review panels
- Clinical Chemistry (91)
- Immunology (30)
- Hematology (1)
- Pathology (1)
Most recent Wako Chemicals USA, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K100464 | UTASWAKO I30 (INCLUDES ACCESSORIES), UTASWAKO AFP-L3, CALIBRATOR SET, CONTROL L, CONTROL H, SAMPLE DILUTION | NSF | 2011-02-23 | 370 |
| K080125 | APOLOWAKO T-CHO, HDL-C, TG AND ANALYZER, MODELS 993-23501, 999-23601, 995-23701 AND 993-25201 | LBS | 2008-07-18 | 183 |
| K080123 | APOLOWAKO HBA1C, GLUCOSE AND ANALYZER, MODELS 993-24601, 991-24401 AND 993-25201 | CFR | 2008-07-17 | 182 |
| K061775 | WAKO L-TYPE CREATININE-M TEST, AND WAKO CREATININE CALIBRATOR | JFY | 2007-02-23 | 245 |
| K062368 | WAKO LBA DCP TEST SYSTEM, MODEL 993-05301; DCP CONTROL SET, MODEL 995-0551; DCP CALIBRATOR SET, LIBASYS, MODEL 999-05401 | OAU | 2007-01-31 | 170 |
| K053132 | WAKO DIRECT BILIRUBIN V, MODELS 996-23591, 412-22901, 992-23691, 998-23791 | JFM | 2005-12-30 | 52 |
| K053131 | WAKO TOTAL BILIRUBIN V, MODELS 410-22701, 998-23291, 416-22801, 990-23191 | JFM | 2005-12-30 | 52 |
| K042551 | MULTI-CHEM CALIBRATOR A | JIX | 2004-11-16 | 57 |
| K042550 | MULTI-LIPID CALIBRATOR | JIX | 2004-11-08 | 49 |
| K042549 | MULTI CHEM CAL B | JIX | 2004-11-08 | 49 |
113 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN050002 | De Novo | Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment | 2005-05-19 |
Recalls
3 product recalls in 3 recall events; 0 initiated in the last five years. Most recent: 2012-01-30.
7 product recalls in 5 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Siemens Healthcare Diagnostics, Inc. (3), Fujifilm Medical Systems U.S.A., Inc. (2), Abbott Point of Care Inc. (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Wako Pure Chemical Industries, Ltd. (6 510(k)s)
- Wako Intl., Inc. (4 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Wako Chemicals USA, Inc.?
FDA lists 123 510(k) clearances under the applicant name “Wako Chemicals USA, Inc.” (first 1981, latest 2011), plus 1 De Novo decision, across 59 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Wako Chemicals USA, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Wako Chemicals USA, Inc. is 52 days.
Which FDA product codes appear under Wako Chemicals USA, Inc.?
The most frequent FDA product codes under this applicant name are JIT (Calibrator, Secondary, 15); DFC (Lipoprotein, Low-Density, Antigen, Antiserum, Control, 9); JIS (Calibrator, Primary, 7).
Next steps
- See all 123 Wako Chemicals USA, Inc. clearances with predicates and recalls
- Run predicate analysis for product code JIT, Wako Chemicals USA, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.